Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Figlin

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
The Urologic Clinics of North America|November 1, 1994
Management of disseminated kidney cancerS S Taneja, W Pierce, R Figlin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Oral vinzolidine as therapy for Kaposi's sarcoma and carcinomas of lung, breast, and colon/rectumG Sarna, R Mitsuyasu, R Figlin, et al.
The Journal of Urology|June 24, 1999
Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapyJ Naitoh, A Kaplan, F Dorey, et al.
Acta Urologica Belgica|December 1, 1993
Pathologic response and long term results of preoperative M-VAC regimen in regionally advanced transitional cell carcinoma of the bladderA S Abi-Aad, A Stenzl, R Figlin, et al.
Seminars in Urologic Oncology|November 1, 1996
Cytoreductive surgery in the management of metastatic renal cell carcinoma: the UCLA experienceJ R Franklin, R Figlin, J Rauch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapyT Cangiano, J Liao, J Naitoh, et al.
Journal of Biological Response Modifiers|February 1, 1990
A pilot study of intralymphatic interleukin-2. II. Clinical and biological effectsG Sarna, J Collins, R Figlin, et al.
The Cancer Journal From Scientific American|February 19, 1998
A phase II study of recombinant human interleukin-4 for advanced or recurrent non-small cell lung cancerE E Vokes, R Figlin, H Hochster, et al.
British Journal of Cancer|July 1, 1995
The effects of granulocyte-macrophage colony-stimulating factor on tumour-infiltrating lymphocytes from renal cell carcinomaG G Steger, R Kaboo, J B deKernion, et al.
The Journal of Urology|December 1, 1983
The treatment of renal cell carcinoma with human leukocyte alpha-interferonJ B deKernion, G Sarna, R Figlin, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
The Urologic Clinics of North America|November 1, 1994
Management of disseminated kidney cancerS S Taneja, W Pierce, R Figlin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Oral vinzolidine as therapy for Kaposi's sarcoma and carcinomas of lung, breast, and colon/rectumG Sarna, R Mitsuyasu, R Figlin, et al.
The Journal of Urology|June 24, 1999
Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapyJ Naitoh, A Kaplan, F Dorey, et al.
Acta Urologica Belgica|December 1, 1993
Pathologic response and long term results of preoperative M-VAC regimen in regionally advanced transitional cell carcinoma of the bladderA S Abi-Aad, A Stenzl, R Figlin, et al.
Seminars in Urologic Oncology|November 1, 1996
Cytoreductive surgery in the management of metastatic renal cell carcinoma: the UCLA experienceJ R Franklin, R Figlin, J Rauch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapyT Cangiano, J Liao, J Naitoh, et al.
Journal of Biological Response Modifiers|February 1, 1990
A pilot study of intralymphatic interleukin-2. II. Clinical and biological effectsG Sarna, J Collins, R Figlin, et al.
The Cancer Journal From Scientific American|February 19, 1998
A phase II study of recombinant human interleukin-4 for advanced or recurrent non-small cell lung cancerE E Vokes, R Figlin, H Hochster, et al.
British Journal of Cancer|July 1, 1995
The effects of granulocyte-macrophage colony-stimulating factor on tumour-infiltrating lymphocytes from renal cell carcinomaG G Steger, R Kaboo, J B deKernion, et al.
The Journal of Urology|December 1, 1983
The treatment of renal cell carcinoma with human leukocyte alpha-interferonJ B deKernion, G Sarna, R Figlin, et al.
Pageof 5